Top compounds associated with response to PLA1A


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.062 0.07
mRNA JW-7-24-1 GDSC1000 pan-cancer AAC -0.057 0.08
mRNA masitinib GDSC1000 pan-cancer AAC -0.062 0.08
mRNA Cytarabine GDSC1000 pan-cancer AAC -0.068 0.08
mRNA Methotrexate CTRPv2 pan-cancer AAC -0.064 0.08
mRNA Gemcitabine GDSC1000 pan-cancer AAC -0.066 0.08
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.061 0.08
mRNA Salubrinal GDSC1000 pan-cancer AAC -0.096 0.08
mRNA VNLG/124 GDSC1000 pan-cancer AAC -0.061 0.08
mRNA dexamethasone CTRPv2 pan-cancer AAC -0.057 0.08
Download CSV